SlideShare a Scribd company logo

GTPs vs. cGMPs

•Download as PPT, PDF•
•
W
wrtolbert

The document discusses regulations for human cells, tissues, and cellular and tissue-based products (HCT/Ps) established by the U.S. Food and Drug Administration (FDA) under 21 CFR Part 1271. It provides an overview of the key requirements including establishment registration and listing, donor eligibility screening, adherence to current good tissue practice standards, inspection and enforcement, and the tiered regulatory framework for HCT/Ps. It also compares the new regulations to existing cGMP and quality system regulations.

1 of 52
WR Tolbert & Associates Consultants to the Biopharmaceutical Industry 11483 Cypress Woods Drive San Diego, CA 92131-3535 858-693-8163 wrt@wrtolbert.com / www.wrtolbert.com
Dogs Bark, Cows Moo, Regulators Regulate... Frank Young, M.D. former FDA Commissioner
FDA History ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
FDA’s Purpose ,[object Object],[object Object],[object Object],[object Object],[object Object]
FDA “Centers” ,[object Object],[object Object],[object Object]
FDA Inspections ,[object Object],[object Object]
Foreign Regulatory Agencies ,[object Object],[object Object],[object Object],[object Object]
Information Sources ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Information Sources ,[object Object],[object Object],[object Object]
The Primary Requirement / Roadblock ,[object Object],[object Object],[object Object],[object Object],[object Object]
FDA Tools ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Cross Regulation Themes and Concerns ,[object Object],[object Object],[object Object],[object Object],[object Object]
The Existing Regulatory Environment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
How are Cell-Based Products Different? ,[object Object],[object Object],[object Object],[object Object]
FDA Driving Forces & Challenges for Cell Products ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Cell and Tissue Characteristics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
FDA Regulation of Cellular and Tissue-based Products ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
New FDA Regulation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
21 CFR Part 1271
Regulatory Requirements for HCT/P’s
21 CFR Part 1271 Establishment Registration and Listing ,[object Object],[object Object],[object Object]
21 CFR Part 1271 Donor Eligibility ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
21 CFR Part 1271 Good Tissue Practices ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
21 CFR Part 1271 Inspection and Enforcement ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
21 CFR Part 1271 Inspection and Enforcement ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Compliance to cGMPs, QSRs, and Biologics Regulations vs. cGTPs ,[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison cGMPs vs. cGTPs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
FDA Inspections ,[object Object],[object Object],[object Object],[object Object],[object Object]
cGMP Sanctions ,[object Object],[object Object],[object Object]
Additional Valuable cGMP Information ,[object Object],[object Object],[object Object],[object Object]
Open vs. Closed Manufacturing Systems ,[object Object],[object Object]
WRT&A
Material and Supply Flow WRT&A
WRT&A
WRT&A

Recommended

FDA Inspection
FDA InspectionFDA Inspection
FDA InspectionInstitute of Validation Technology
 
21 cfr, parts 210 211
21 cfr, parts 210 21121 cfr, parts 210 211
21 cfr, parts 210 211Compliance Insight, Inc.
 
Fda Inspection
Fda InspectionFda Inspection
Fda InspectionCompliance Insight, Inc.
 
FDA Inspection Readiness.pptx
FDA Inspection Readiness.pptxFDA Inspection Readiness.pptx
FDA Inspection Readiness.pptxGeorgeVardas2
 
Getting to know 21 cfr 210 and 211 by micah thomas with speaker notes update ...
Getting to know 21 cfr 210 and 211 by micah thomas with speaker notes update ...Getting to know 21 cfr 210 and 211 by micah thomas with speaker notes update ...
Getting to know 21 cfr 210 and 211 by micah thomas with speaker notes update ...Micah Thomas
 
History of gmp
History of gmpHistory of gmp
History of gmpkamyar faghihi
 
current Good Tissue Practice
current Good Tissue Practice current Good Tissue Practice
current Good Tissue Practice Arete-Zoe, LLC
 
Good Manufacturing Practices(GMP)
Good Manufacturing Practices(GMP)Good Manufacturing Practices(GMP)
Good Manufacturing Practices(GMP)Virendra Singh
 

Recommended

FDA Inspection
FDA InspectionFDA Inspection
FDA InspectionInstitute of Validation Technology
 
21 cfr, parts 210 211
21 cfr, parts 210 21121 cfr, parts 210 211
21 cfr, parts 210 211Compliance Insight, Inc.
 
Fda Inspection
Fda InspectionFda Inspection
Fda InspectionCompliance Insight, Inc.
 
FDA Inspection Readiness.pptx
FDA Inspection Readiness.pptxFDA Inspection Readiness.pptx
FDA Inspection Readiness.pptxGeorgeVardas2
 
Getting to know 21 cfr 210 and 211 by micah thomas with speaker notes update ...
Getting to know 21 cfr 210 and 211 by micah thomas with speaker notes update ...Getting to know 21 cfr 210 and 211 by micah thomas with speaker notes update ...
Getting to know 21 cfr 210 and 211 by micah thomas with speaker notes update ...Micah Thomas
 
History of gmp
History of gmpHistory of gmp
History of gmpkamyar faghihi
 
current Good Tissue Practice
current Good Tissue Practice current Good Tissue Practice
current Good Tissue Practice Arete-Zoe, LLC
 
Good Manufacturing Practices(GMP)
Good Manufacturing Practices(GMP)Good Manufacturing Practices(GMP)
Good Manufacturing Practices(GMP)Virendra Singh
 
Prior Approval Supplements (PAS)
Prior Approval Supplements (PAS)Prior Approval Supplements (PAS)
Prior Approval Supplements (PAS)Nirma University
 
Doc in pharma
Doc in pharmaDoc in pharma
Doc in pharmamaitreyi zaveri
 
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...eCTDconsultancy
 
FDA Warning Letter
FDA Warning LetterFDA Warning Letter
FDA Warning LetterCompliance Insight, Inc.
 
21 cfr part 50
21 cfr part 5021 cfr part 50
21 cfr part 50Rohit K.
 
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATESQUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATESvasanthi chodavarapu
 
GMP
GMPGMP
GMPAtlantic Training, LLC.
 
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning LettersHow to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning LettersGreenlight Guru
 
Preparing For An FDA Inspection - Employee Review
Preparing For An FDA Inspection - Employee ReviewPreparing For An FDA Inspection - Employee Review
Preparing For An FDA Inspection - Employee Reviewguest22cdb3
 
Drug Master Files under GDUFA
Drug Master Files under GDUFADrug Master Files under GDUFA
Drug Master Files under GDUFAGMP EDUCATION : Not for Profit Organization
 
Electronic Submissions
Electronic SubmissionsElectronic Submissions
Electronic SubmissionsMedTech Review, LLC
 
History & Evolution of GMP Regulations
History & Evolution of GMP RegulationsHistory & Evolution of GMP Regulations
History & Evolution of GMP RegulationsGMP EDUCATION : Not for Profit Organization
 
FDA PreApproval Inspection - Part 1
FDA PreApproval Inspection - Part 1FDA PreApproval Inspection - Part 1
FDA PreApproval Inspection - Part 1Jorge Torres
 
EU MDD.pptx
EU MDD.pptxEU MDD.pptx
EU MDD.pptxAartiVats5
 
Review of-batch-production-records
Review of-batch-production-recordsReview of-batch-production-records
Review of-batch-production-recordsDr. Ray Ziai
 
GHTF
GHTFGHTF
GHTFKDivya11
 
Handling FDA Inspection - Do's and Dont's
Handling FDA Inspection - Do's and Dont'sHandling FDA Inspection - Do's and Dont's
Handling FDA Inspection - Do's and Dont'sArun Purohit
 
Drug Registration in ASEAN Countries.pptx
Drug Registration in ASEAN Countries.pptxDrug Registration in ASEAN Countries.pptx
Drug Registration in ASEAN Countries.pptxbhavuk11
 
Good Automated Laboratory Practices
Good Automated Laboratory PracticesGood Automated Laboratory Practices
Good Automated Laboratory PracticesSwapnil Fernandes
 
ICH Q7 Guideline
ICH Q7 GuidelineICH Q7 Guideline
ICH Q7 GuidelinePrashant Bharadva
 
Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...
Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...
Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...wrtolbert
 
FDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection IntelligenceFDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection IntelligenceArmin Torres
 

More Related Content

What's hot

Prior Approval Supplements (PAS)
Prior Approval Supplements (PAS)Prior Approval Supplements (PAS)
Prior Approval Supplements (PAS)Nirma University
 
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...eCTDconsultancy
 
21 cfr part 50
21 cfr part 5021 cfr part 50
21 cfr part 50Rohit K.
 
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATESQUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATESvasanthi chodavarapu
 
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning LettersHow to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning LettersGreenlight Guru
 
Preparing For An FDA Inspection - Employee Review
Preparing For An FDA Inspection - Employee ReviewPreparing For An FDA Inspection - Employee Review
Preparing For An FDA Inspection - Employee Reviewguest22cdb3
 
FDA PreApproval Inspection - Part 1
FDA PreApproval Inspection - Part 1FDA PreApproval Inspection - Part 1
FDA PreApproval Inspection - Part 1Jorge Torres
 
Review of-batch-production-records
Review of-batch-production-recordsReview of-batch-production-records
Review of-batch-production-recordsDr. Ray Ziai
 
Handling FDA Inspection - Do's and Dont's
Handling FDA Inspection - Do's and Dont'sHandling FDA Inspection - Do's and Dont's
Handling FDA Inspection - Do's and Dont'sArun Purohit
 
Drug Registration in ASEAN Countries.pptx
Drug Registration in ASEAN Countries.pptxDrug Registration in ASEAN Countries.pptx
Drug Registration in ASEAN Countries.pptxbhavuk11
 
Good Automated Laboratory Practices
Good Automated Laboratory PracticesGood Automated Laboratory Practices
Good Automated Laboratory PracticesSwapnil Fernandes
 

What's hot (20)

Prior Approval Supplements (PAS)
Prior Approval Supplements (PAS)Prior Approval Supplements (PAS)
Prior Approval Supplements (PAS)
 
Doc in pharma
Doc in pharmaDoc in pharma
Doc in pharma
 
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...
 
FDA Warning Letter
FDA Warning LetterFDA Warning Letter
FDA Warning Letter
 
21 cfr part 50
21 cfr part 5021 cfr part 50
21 cfr part 50
 
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATESQUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
 
GMP
GMPGMP
GMP
 
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning LettersHow to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
 
Preparing For An FDA Inspection - Employee Review
Preparing For An FDA Inspection - Employee ReviewPreparing For An FDA Inspection - Employee Review
Preparing For An FDA Inspection - Employee Review
 
Drug Master Files under GDUFA
Drug Master Files under GDUFADrug Master Files under GDUFA
Drug Master Files under GDUFA
 
Electronic Submissions
Electronic SubmissionsElectronic Submissions
Electronic Submissions
 
History & Evolution of GMP Regulations
History & Evolution of GMP RegulationsHistory & Evolution of GMP Regulations
History & Evolution of GMP Regulations
 
FDA PreApproval Inspection - Part 1
FDA PreApproval Inspection - Part 1FDA PreApproval Inspection - Part 1
FDA PreApproval Inspection - Part 1
 
EU MDD.pptx
EU MDD.pptxEU MDD.pptx
EU MDD.pptx
 
Review of-batch-production-records
Review of-batch-production-recordsReview of-batch-production-records
Review of-batch-production-records
 
GHTF
GHTFGHTF
GHTF
 
Handling FDA Inspection - Do's and Dont's
Handling FDA Inspection - Do's and Dont'sHandling FDA Inspection - Do's and Dont's
Handling FDA Inspection - Do's and Dont's
 
Drug Registration in ASEAN Countries.pptx
Drug Registration in ASEAN Countries.pptxDrug Registration in ASEAN Countries.pptx
Drug Registration in ASEAN Countries.pptx
 
Good Automated Laboratory Practices
Good Automated Laboratory PracticesGood Automated Laboratory Practices
Good Automated Laboratory Practices
 
ICH Q7 Guideline
ICH Q7 GuidelineICH Q7 Guideline
ICH Q7 Guideline
 

Viewers also liked

Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...
Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...
Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...wrtolbert
 
FDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection IntelligenceFDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection IntelligenceArmin Torres
 
Stem cells: Information environment
Stem cells: Information environmentStem cells: Information environment
Stem cells: Information environmentArete-Zoe, LLC
 
Gmp premises 112070804006
Gmp premises 112070804006Gmp premises 112070804006
Gmp premises 112070804006Patel Parth
 
Quality Assurance Vs Quality Control
Quality Assurance Vs Quality ControlQuality Assurance Vs Quality Control
Quality Assurance Vs Quality ControlYogita patil
 
InstantGMP Compliance Series - Facility Areas
InstantGMP Compliance Series - Facility AreasInstantGMP Compliance Series - Facility Areas
InstantGMP Compliance Series - Facility AreasInstantGMP™
 

Viewers also liked (9)

Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...
Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...
Gene Therapy / Cell Therapy / Stem Cells – Regulations for the "New Biol...
 
FDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection IntelligenceFDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection Intelligence
 
Stem cells: Information environment
Stem cells: Information environmentStem cells: Information environment
Stem cells: Information environment
 
Gmp & glp
Gmp & glpGmp & glp
Gmp & glp
 
Gmp premises 112070804006
Gmp premises 112070804006Gmp premises 112070804006
Gmp premises 112070804006
 
GMP
GMPGMP
GMP
 
Quality Assurance Vs Quality Control
Quality Assurance Vs Quality ControlQuality Assurance Vs Quality Control
Quality Assurance Vs Quality Control
 
InstantGMP Compliance Series - Facility Areas
InstantGMP Compliance Series - Facility AreasInstantGMP Compliance Series - Facility Areas
InstantGMP Compliance Series - Facility Areas
 
Pharmaceutical manufacturing plant
Pharmaceutical manufacturing plantPharmaceutical manufacturing plant
Pharmaceutical manufacturing plant
 

Similar to GTPs vs. cGMPs

Good Manufacturing Practices
Good Manufacturing PracticesGood Manufacturing Practices
Good Manufacturing PracticesJorge Torres
 
FDA 2013 Clinical Investigator Training Course: How to put together an Applic...
FDA 2013 Clinical Investigator Training Course: How to put together an Applic...FDA 2013 Clinical Investigator Training Course: How to put together an Applic...
FDA 2013 Clinical Investigator Training Course: How to put together an Applic...MedicReS
 
Regulation of Medical Devices in US
Regulation of Medical Devices in USRegulation of Medical Devices in US
Regulation of Medical Devices in USAnkit Geete
 
USFDA GUIDLINES
USFDA GUIDLINESUSFDA GUIDLINES
USFDA GUIDLINESRaj Tiwari
 
Understanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical DevicesUnderstanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical Devicesmarchell
 
Planning Clinical Trial in USA.pdf
Planning Clinical Trial in USA.pdfPlanning Clinical Trial in USA.pdf
Planning Clinical Trial in USA.pdfProRelix Research
 
Understanding FDA Regulations
Understanding FDA RegulationsUnderstanding FDA Regulations
Understanding FDA RegulationsBeth Friedland
 
Quality regulation for biological products current and future
Quality regulation for biological products current and futureQuality regulation for biological products current and future
Quality regulation for biological products current and futureNational Institute of Biologics
 
FDA Regulations and Medical Device Pathways to Market
FDA Regulations and Medical Device Pathways to MarketFDA Regulations and Medical Device Pathways to Market
FDA Regulations and Medical Device Pathways to MarketMethodSense, Inc.
 
FDA Regulations and Medical Device Pathways to Market
FDA Regulations and Medical Device Pathways to MarketFDA Regulations and Medical Device Pathways to Market
FDA Regulations and Medical Device Pathways to MarketMethodSense, Inc.
 
Avoiding Pitfalls in the Regulatory Path - MaRS Best Practices
Avoiding Pitfalls in the Regulatory Path - MaRS Best PracticesAvoiding Pitfalls in the Regulatory Path - MaRS Best Practices
Avoiding Pitfalls in the Regulatory Path - MaRS Best PracticesMaRS Discovery District
 
Regulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsRegulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsArpitha Aarushi
 
FDA classify Medical Devices and how to report device problems A Systematic R...
FDA classify Medical Devices and how to report device problems A Systematic R...FDA classify Medical Devices and how to report device problems A Systematic R...
FDA classify Medical Devices and how to report device problems A Systematic R...Pubrica
 
FDA 2013 Clinical Investigator Training Course: FDA Structure and Mandate
FDA 2013 Clinical Investigator Training Course: FDA Structure and Mandate FDA 2013 Clinical Investigator Training Course: FDA Structure and Mandate
FDA 2013 Clinical Investigator Training Course: FDA Structure and Mandate MedicReS
 
DESIGN OF IMPLANTABLE DEVICE – UNDERSTANDING THE PREMARKET REVIEW PROCESS AN...
DESIGN OF IMPLANTABLE DEVICE – UNDERSTANDING THE PREMARKET REVIEW PROCESS AN...DESIGN OF IMPLANTABLE DEVICE – UNDERSTANDING THE PREMARKET REVIEW PROCESS AN...
DESIGN OF IMPLANTABLE DEVICE – UNDERSTANDING THE PREMARKET REVIEW PROCESS AN...UBMCanon
 
Chap2 CTPMR, 2nd Ed. 2016
Chap2 CTPMR, 2nd Ed. 2016Chap2 CTPMR, 2nd Ed. 2016
Chap2 CTPMR, 2nd Ed. 2016Eric Dollins
 
The Rough Waters of the Regulatory Environment
The Rough Waters of the Regulatory EnvironmentThe Rough Waters of the Regulatory Environment
The Rough Waters of the Regulatory EnvironmentJonathan Servoss
 

Similar to GTPs vs. cGMPs (20)

Good Manufacturing Practices
Good Manufacturing PracticesGood Manufacturing Practices
Good Manufacturing Practices
 
FDA 2013 Clinical Investigator Training Course: How to put together an Applic...
FDA 2013 Clinical Investigator Training Course: How to put together an Applic...FDA 2013 Clinical Investigator Training Course: How to put together an Applic...
FDA 2013 Clinical Investigator Training Course: How to put together an Applic...
 
Regulation of Medical Devices in US
Regulation of Medical Devices in USRegulation of Medical Devices in US
Regulation of Medical Devices in US
 
USFDA GUIDLINES
USFDA GUIDLINESUSFDA GUIDLINES
USFDA GUIDLINES
 
Understanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical DevicesUnderstanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical Devices
 
Planning Clinical Trial in USA.pdf
Planning Clinical Trial in USA.pdfPlanning Clinical Trial in USA.pdf
Planning Clinical Trial in USA.pdf
 
Understanding FDA Regulations
Understanding FDA RegulationsUnderstanding FDA Regulations
Understanding FDA Regulations
 
Quality regulation for biological products current and future
Quality regulation for biological products current and futureQuality regulation for biological products current and future
Quality regulation for biological products current and future
 
FDA Regulations
FDA RegulationsFDA Regulations
FDA Regulations
 
FDA Regulations and Medical Device Pathways to Market
FDA Regulations and Medical Device Pathways to MarketFDA Regulations and Medical Device Pathways to Market
FDA Regulations and Medical Device Pathways to Market
 
FDA Regulations and Medical Device Pathways to Market
FDA Regulations and Medical Device Pathways to MarketFDA Regulations and Medical Device Pathways to Market
FDA Regulations and Medical Device Pathways to Market
 
Avoiding Pitfalls in the Regulatory Path - MaRS Best Practices
Avoiding Pitfalls in the Regulatory Path - MaRS Best PracticesAvoiding Pitfalls in the Regulatory Path - MaRS Best Practices
Avoiding Pitfalls in the Regulatory Path - MaRS Best Practices
 
Gcp
GcpGcp
Gcp
 
Advamed MDR IVDR update
Advamed MDR IVDR updateAdvamed MDR IVDR update
Advamed MDR IVDR update
 
Regulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsRegulatory requirement for approval of Biologics
Regulatory requirement for approval of Biologics
 
FDA classify Medical Devices and how to report device problems A Systematic R...
FDA classify Medical Devices and how to report device problems A Systematic R...FDA classify Medical Devices and how to report device problems A Systematic R...
FDA classify Medical Devices and how to report device problems A Systematic R...
 
FDA 2013 Clinical Investigator Training Course: FDA Structure and Mandate
FDA 2013 Clinical Investigator Training Course: FDA Structure and Mandate FDA 2013 Clinical Investigator Training Course: FDA Structure and Mandate
FDA 2013 Clinical Investigator Training Course: FDA Structure and Mandate
 
DESIGN OF IMPLANTABLE DEVICE – UNDERSTANDING THE PREMARKET REVIEW PROCESS AN...
DESIGN OF IMPLANTABLE DEVICE – UNDERSTANDING THE PREMARKET REVIEW PROCESS AN...DESIGN OF IMPLANTABLE DEVICE – UNDERSTANDING THE PREMARKET REVIEW PROCESS AN...
DESIGN OF IMPLANTABLE DEVICE – UNDERSTANDING THE PREMARKET REVIEW PROCESS AN...
 
Chap2 CTPMR, 2nd Ed. 2016
Chap2 CTPMR, 2nd Ed. 2016Chap2 CTPMR, 2nd Ed. 2016
Chap2 CTPMR, 2nd Ed. 2016
 
The Rough Waters of the Regulatory Environment
The Rough Waters of the Regulatory EnvironmentThe Rough Waters of the Regulatory Environment
The Rough Waters of the Regulatory Environment
 

GTPs vs. cGMPs

  • 1. WR Tolbert & Associates Consultants to the Biopharmaceutical Industry 11483 Cypress Woods Drive San Diego, CA 92131-3535 858-693-8163 wrt@wrtolbert.com / www.wrtolbert.com
  • 2. Dogs Bark, Cows Moo, Regulators Regulate... Frank Young, M.D. former FDA Commissioner
  • 3.
  • 4.  
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20. 21 CFR Part 1271
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.
  • 45.
  • 46.
  • 47.
  • 48.
  • 49. WRT&A
  • 50. Material and Supply Flow WRT&A
  • 51. WRT&A
  • 52. WRT&A